Recombinant Human Adenovirus

Adenovirus vector

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Human Adenovirus, covering 2017-03-16 to 2017-03-16. Get the full timeline:

Most recent: Clinical Trial Update: TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma [Phase 3]